Advancing CAR T-cell strategies for solid tumors remains a key focus in IO and a recent #JITC study by Diego Salas-Benito et al explores targeting both mesothelin and MUC16. These approaches compliment new CAR T-cell therapy data presented by J.R. Choo at #AACR26. Learn more: